Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks.

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...

The white blood cells in question are cytotoxic T lymphocytes (CTLs), also known as killer T cells. These "warrior" cells ...

A newly discovered "timekeeper" for fighting infections dramatically shapes the body's immune defenses, offering insight as to why antiviral T cell response varies throughout the day, according to UT ...

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma. The investigational allogeneic chimeric ...

The SCG2 hormone allows tumors to suppress immune defenses, opening up a new therapeutic avenue against cancer.

People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus. For most individuals, this constant exposure is harmless, as the immune ...

After decades of trials into pathways that ultimately failed in Sjögren’s disease, recent efforts targeting B cells have ...